ARCHIVES

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Seattle Times, The Hutch Duel Over Five-Part Series.

March 23, 2001

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006

In Brief: Congressmen Press Or More Exploratory Grant Money: Murphy Reelected By UICC

August 6, 1976

HHS Inquiry Triggers Sloppy Stories On Gallo’s Laboratory

July 21, 1989

In Brief: Newell Denies He’s Leaving For Job On West Coast, Says He Is A “Free Agent”

November 4, 1977

Kimmel Foundation To Donate $1 million for Cancer Research

June 28, 1996